MMSI Quote, Financials, Valuation and Earnings

ICU Medical has a net margin of 8.48% compared to Merit Medical Systems's net margin of -2.56%. Merit Medical Systems's return on equity of 9.19% beat ICU Medical's return on equity of -4.64%.

Merit Medical Systems has a consensus price target of $108.73, signalling upside risk potential of 29.51%. On the other hand ICU Medical has an analysts' consensus of $186.20 which suggests that it could grow by 49.16%. Given that ICU Medical has higher upside potential than Merit Medical Systems, analysts believe ICU Medical is more attractive than Merit Medical Systems.

Merit Medical Systems has a beta of 0.646, which suggesting that the stock is 35.358% less volatile than S&P 500. In comparison ICU Medical has a beta of 0.870, suggesting its less volatile than the S&P 500 by 13.002%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ICU Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. ICU Medical pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.4M, which are smaller than ICU Medical quarterly revenues of $604.7M. Merit Medical Systems's net income of $30.1M is higher than ICU Medical's net income of -$15.5M. Notably, Merit Medical Systems's price-to-earnings ratio is 41.15x while ICU Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 3.63x versus 1.26x for ICU Medical. Usually stocks with elevated PS ratios are considered overvalued.

Integer Holdings has a net margin of 8.48% compared to Merit Medical Systems's net margin of -5.14%. Merit Medical Systems's return on equity of 9.19% beat Integer Holdings's return on equity of 4.85%.

Merit Medical Systems has a consensus price target of $108.73, signalling upside risk potential of 29.51%. On the other hand Integer Holdings has an analysts' consensus of $148.75 which suggests that it could grow by 27%. Given that Merit Medical Systems has higher upside potential than Integer Holdings, analysts believe Merit Medical Systems is more attractive than Integer Holdings.

Merit Medical Systems has a beta of 0.646, which suggesting that the stock is 35.358% less volatile than S&P 500. In comparison Integer Holdings has a beta of 0.980, suggesting its less volatile than the S&P 500 by 1.988%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integer Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Integer Holdings pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.4M, which are smaller than Integer Holdings quarterly revenues of $437.4M. Merit Medical Systems's net income of $30.1M is higher than Integer Holdings's net income of -$22.5M. Notably, Merit Medical Systems's price-to-earnings ratio is 41.15x while Integer Holdings's PE ratio is 55.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 3.63x versus 2.36x for Integer Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Masimo has a net margin of 8.48% compared to Merit Medical Systems's net margin of -45.89%. Merit Medical Systems's return on equity of 9.19% beat Masimo's return on equity of -39.91%.

Merit Medical Systems has a consensus price target of $108.73, signalling upside risk potential of 29.51%. On the other hand Masimo has an analysts' consensus of $184.37 which suggests that it could grow by 15.63%. Given that Merit Medical Systems has higher upside potential than Masimo, analysts believe Merit Medical Systems is more attractive than Masimo.

Merit Medical Systems has a beta of 0.646, which suggesting that the stock is 35.358% less volatile than S&P 500. In comparison Masimo has a beta of 1.187, suggesting its more volatile than the S&P 500 by 18.716%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Masimo pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.4M, which are smaller than Masimo quarterly revenues of $372M. Merit Medical Systems's net income of $30.1M is higher than Masimo's net income of -$170.7M. Notably, Merit Medical Systems's price-to-earnings ratio is 41.15x while Masimo's PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 3.63x versus 4.38x for Masimo. Usually stocks with elevated PS ratios are considered overvalued.

ResMed has a net margin of 8.48% compared to Merit Medical Systems's net margin of 28.26%. Merit Medical Systems's return on equity of 9.19% beat ResMed's return on equity of 25.76%.

Merit Medical Systems has a consensus price target of $108.73, signalling upside risk potential of 29.51%. On the other hand ResMed has an analysts' consensus of $269.49 which suggests that it could grow by 5.99%. Given that Merit Medical Systems has higher upside potential than ResMed, analysts believe Merit Medical Systems is more attractive than ResMed.

Merit Medical Systems has a beta of 0.646, which suggesting that the stock is 35.358% less volatile than S&P 500. In comparison ResMed has a beta of 0.774, suggesting its less volatile than the S&P 500 by 22.603%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ResMed offers a yield of 0.83% to investors and pays a quarterly dividend of $0.53 per share. Merit Medical Systems pays -- of its earnings as a dividend. ResMed pays out 27.65% of its earnings as a dividend. ResMed's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Merit Medical Systems quarterly revenues are $355.4M, which are smaller than ResMed quarterly revenues of $1.3B. Merit Medical Systems's net income of $30.1M is lower than ResMed's net income of $365M. Notably, Merit Medical Systems's price-to-earnings ratio is 41.15x while ResMed's PE ratio is 28.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 3.63x versus 7.47x for ResMed. Usually stocks with elevated PS ratios are considered overvalued.